HomePodcastsThe Long Run with Luke TimmermanEp201: Jeremy Levin on Biotech in the BalanceThe Long Run with Luke TimmermanEp201: Jeremy Levin on Biotech in the BalanceMay 19, 2026 · 1 h 9 minPlay episodeShare from this pointShow notesJeremy Levin, executive chair of Ovid Therapeutics, discusses his new book "Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust."All episodes of The Long Run with Luke Timmerman